Patriot Financial Group Insurance Agency’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-30
Closed -$1K 1462
2019
Q1
$1K Hold
30
﹤0.01% 1158
2018
Q4
$1K Hold
30
﹤0.01% 939
2018
Q3
$1K Buy
+30
New +$901 ﹤0.01% 936
2018
Q2
Sell
-30
Closed -$1K 854
2018
Q1
$1K Hold
30
﹤0.01% 928
2017
Q4
$1K Hold
30
﹤0.01% 915
2017
Q3
$1K Hold
30
﹤0.01% 891
2017
Q2
$1K Hold
30
﹤0.01% 897
2017
Q1
$1K Hold
30
﹤0.01% 802
2016
Q4
$1K Buy
+30
New +$859 ﹤0.01% 745

Other funds holding RIGL

Patriot Financial Group Insurance Agency's RIGL Position: Q2 2019 in Review

Patriot Financial Group Insurance Agency sold out of Rigel Pharmaceuticals (RIGL) in Q2 2019, closing a stake of 30 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in RIGL in Q4 2016 and held it in 9 quarters. The position peaked at $1K in Q1 2019. 127 funds tracked by Wall St. Rank hold RIGL as of Q2 2019.

  • Patriot Financial Group Insurance Agency reported no remaining Rigel Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 30 Rigel Pharmaceuticals shares in Q2 2019, an estimated $1K.
  • Patriot Financial Group Insurance Agency first reported a position in Rigel Pharmaceuticals in Q4 2016 and held it in 9 quarters.
  • Patriot Financial Group Insurance Agency's Rigel Pharmaceuticals position peaked at $1K in Q1 2019.
  • 127 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2019.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q2 2019, filed 7 Aug 2019.